1-24120978-G-C
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_021258.4(IL22RA1):c.1552C>G(p.Arg518Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.415 in 1,613,892 control chromosomes in the GnomAD database, including 143,196 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_021258.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IL22RA1 | NM_021258.4 | c.1552C>G | p.Arg518Gly | missense_variant | 7/7 | ENST00000270800.2 | NP_067081.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IL22RA1 | ENST00000270800.2 | c.1552C>G | p.Arg518Gly | missense_variant | 7/7 | 1 | NM_021258.4 | ENSP00000270800 | P1 |
Frequencies
GnomAD3 genomes AF: 0.385 AC: 58488AN: 151996Hom.: 11827 Cov.: 33
GnomAD3 exomes AF: 0.419 AC: 105330AN: 251216Hom.: 23296 AF XY: 0.423 AC XY: 57370AN XY: 135762
GnomAD4 exome AF: 0.418 AC: 610955AN: 1461778Hom.: 131370 Cov.: 63 AF XY: 0.420 AC XY: 305292AN XY: 727188
GnomAD4 genome AF: 0.385 AC: 58495AN: 152114Hom.: 11826 Cov.: 33 AF XY: 0.386 AC XY: 28669AN XY: 74340
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 66% of patients studied by a panel of primary immunodeficiencies. Number of patients: 58. Only high quality variants are reported. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at